Buprenorphine: its role in preventing HIV transmission and improving the care of HIV-infected patients with opioid dependence.
about
Factors affecting willingness to provide buprenorphine treatment.Clinic-based treatment of opioid-dependent HIV-infected patients versus referral to an opioid treatment program: A randomized trial.The Physician Clinical Support System-Buprenorphine (PCSS-B): a novel project to expand/improve buprenorphine treatment.HIV risk reduction with buprenorphine-naloxone or methadone: findings from a randomized trial.Buprenorphine: a (relatively) new treatment for opioid dependence.Buprenorphine for human immunodeficiency virus/hepatitis C virus-coinfected patients: does it serve as a bridge to hepatitis C virus therapy?Therapeutic drug monitoring of protease inhibitors and efavirenz in HIV-infected individuals with active substance-related disorders.Drug treatment as HIV prevention: a research updateDrug treatment as HIV prevention: expanding treatment options.Opiate addiction therapies and HIV-1 Tat: interactive effects on glial [Ca²⁺]i, oxyradical and neuroinflammatory chemokine production and correlative neurotoxicity.Adherence to HIV treatment and care among previously homeless jail detainees.Opioid dependence: rationale for and efficacy of existing and new treatments.Pharmacokinetic interactions between buprenorphine and antiretroviral medications.Opioid maintenance treatment as a harm reduction tool for opioid-dependent individuals in New York City: the need to expand access to buprenorphine/naloxone in marginalized populations.Nurse practitioner and physician assistant interest in prescribing buprenorphine.Moving HIV pre-exposure prophylaxis into clinical settings: lessons from buprenorphineAdvances in the prevention of heterosexual transmission of HIV/AIDS among women in the United States.Retention in methadone and buprenorphine treatment among African Americans.Predictors of abstinence: National Institute of Drug Abuse multisite buprenorphine/naloxone treatment trial in opioid-dependent youthIntegration and co-location of HIV/AIDS, tuberculosis and drug treatment services.Advances in the treatment of opioid use disorders.A mixed methods study of HIV-related services in buprenorphine treatment.Opioid substitution therapy is associated with decreased HIV transmission among people who inject drugs.Opiate Drugs with Abuse Liability Hijack the Endogenous Opioid System to Disrupt Neuronal and Glial Maturation in the Central Nervous System.Risky Sexual Behavior among Individuals receiving Buprenorphine/Naloxone Opiate Dependency Treatment: HIV Prevention Trials Network (HPTN) 058.Infectious Diseases Physicians' Perspectives Regarding Injection Drug Use and Related Infections, United States, 2017
P2860
Q33836333-FFBBA5EB-01A0-4180-A591-783664DB5C08Q33915859-2FD592DD-2BBF-427D-BA16-91772522C8D0Q34050760-4795603A-E53F-4F3D-9632-3A219ADA86EDQ34098066-9F6B6CBA-37B8-4B26-AAE2-B1394AA54C20Q34365302-2FC098E3-301B-4087-B5EC-FB8B25148BC6Q34403692-D7F40B29-7D44-45B3-A9C9-EAB65D07E532Q35061983-10B338BE-6E9D-4A0F-B5BB-73466FE500C5Q35163392-088412AC-D10F-4F9D-9179-DB5ABFF7ECEEQ35163396-04B32D71-E97A-4C7E-805C-A78D2B55123FQ35763921-980431E8-995C-4436-9855-1AE8DBFF1124Q35885979-1808DC93-59FE-4623-92BC-EA9365D8B580Q36655042-DF2E86C6-59C9-4050-B495-9F3357AC8A84Q36655057-60DCEF15-472D-48F8-B17F-1B60F60B654BQ36750914-5CB830A4-E34D-4EB4-AE00-C0E21252ED5AQ36793941-5F4B4C6D-5E46-47ED-A93F-ABF1FEF260F4Q36821137-FF39D469-FCDE-40E5-9A51-9B00F8A246A8Q36899773-123AB8A0-C628-4144-8B94-C8D8D6517C4DQ37022122-F14A5F5E-DE8C-4702-ACFA-C21D25FF666FQ37205781-287B8615-4A83-48A5-AF88-4E7F4C195CF6Q37227121-30FA2F07-D6BD-42BA-9776-C3BB13BBEEBFQ37620473-3576EA2C-EA27-454B-A3D8-63FC7BCFC7C0Q38621655-560C5712-9004-401D-9331-842639521818Q44337554-31CC1708-C99B-42EA-B2CE-AD8D0C72DE33Q49270407-20A6DEDA-81D4-46DE-BAB4-8CD1570412F4Q51365468-BD9D7F6D-906B-430D-A0CB-151777295AB4Q57101945-31A1939B-F5C5-4A7A-A984-7C0AC729E6F9
P2860
Buprenorphine: its role in preventing HIV transmission and improving the care of HIV-infected patients with opioid dependence.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Buprenorphine: its role in pre ...... tients with opioid dependence.
@ast
Buprenorphine: its role in pre ...... tients with opioid dependence.
@en
type
label
Buprenorphine: its role in pre ...... tients with opioid dependence.
@ast
Buprenorphine: its role in pre ...... tients with opioid dependence.
@en
prefLabel
Buprenorphine: its role in pre ...... tients with opioid dependence.
@ast
Buprenorphine: its role in pre ...... tients with opioid dependence.
@en
P356
P1476
Buprenorphine: its role in pre ...... tients with opioid dependence.
@en
P2093
Lynn E Sullivan
P304
P356
10.1086/432888
P407
P577
2005-08-10T00:00:00Z